Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity

Psychopharmacology

Volumn 209, Issue 3, 2010, Pages 233-244

  Li, Xingbao ^a,b   Ricci, Raffaella ^a   Large, Charles H ^c   Anderson, Berry ^a   Nahas, Ziad ^a   Bohning, Daryl E ^b   George, Mark S ^a,b,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c GSK   (Italy)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Anticonvulsant; Corticolimbic system; FMRI; Lamotrigine; Motor cortex; Neuroimaging; Transcranial magnetic stimulation; Valproic acid

Indexed keywords

LAMOTRIGINE; PLACEBO; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; LIMBIC SYSTEM; MORNING DOSAGE; MOTOR CORTEX; NERVE CELL NETWORK; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; BRAIN MAPPING; CEREBRAL CORTEX; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; TRANSCRANIAL MAGNETIC STIMULATION; TRIAZINES; VALPROIC ACID;

EID: 77953293981     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1786-y     Document Type: Article

References (45)

1. Annett M (1970) A classification of hand preference by association analysis. Br J Psychol 61:303-321
2. Baudewig J, Siebner HR, Bestmann S, Tergau F, Tings T, Paulus W, Frahm J (2001) Functional MRI of cortical activations induced by transcranial magnetic stimulation (TMS). Neuroreport 12:3543-3548
3. Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2003) Subthreshold high-frequency TMS of human primary motor cortex modulates interconnected frontal motor areas as detected by interleaved. fMRI-TMS. Neuroimage 20:1685-1696
4. Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2004) Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci 19:1950-1962
5. Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2005) BOLD MRI responses to repetitive TMS over human dorsal premotor cortex. Neuroimage 28:22-29 (Pubitemid 41393884)
6. Bohning DE, Shastri A, Wassermann EM, Ziemann U, Lorberbaum JP, Nanas Z, Lomarev MP, George MS (2000) BOLD-f MRI response to single-pulse transcranial magnetic stimulation (TMS). J Magn Reson Imaging 11:569-574
7. Bohning DE, Denslow S, Bohning PA, Walker JA, George MS (2003) A TMS coil positioning/holding system for MR image-guided TMS interleaved with fMRI. Clin Neurophysiol 114:2210-2219
8. Boroojerdi B, Battaglia F, Muellbacher W, Cohen LG (2001) Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 112:931-937 (Pubitemid 32406270)
9. Borsook D, Becerra L, Hargreaves R (2006) A role for fMRI in optimizing CNS drug development. Nat Rev Drug Discov 5:411-424
10. Cho SS, Strafella AP (2009) rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One 4:e6725
11. Czapinski P, Blaszczyk B, Czuczwar SJ (2005) Mechanisms of action of antiepileptic drugs. CUIT Top Med. Chem 5:3-14
12. SR FMB, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV I disorder. American Psychiatric Association, Washington
13. Fristen KJ, Nahmias C, Shceffel A, Fimau G, Upton A (1994) Assisting the significance of focal, activations using their spatial, extent. Hum Brain Mapp 1:214-220
14. Fristen KJ, Holmes A, Polině JB, Price CJ, Frith CD (1996) Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 4:223-235 (Pubitemid 127742846)
15. Gajwani P, Forsthoff A, Muzina D, Amann B, Gao K, Elhaj O, Calabrese JR, Grunze H (2005) Antiepileptic drugs in mooddisordered patients. Epilepsia 46(Suppl 4):38-44
16. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM (1995) Daily repetitive transcranial magnetic stimulation (rTMS) improves mood, in depression. Neuroreport 6:1853-1856
17. Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R (2004) A pooled analysis of 2 placebocontrolled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432-441
18. Haldane M, Jogia J, Cobb A, Kozuch E, Kumari V, Frangou S (2008) Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol 18:48-54 (Pubitemid 350213388)
19. Herwig U, Padberg F, linger J, Spitzer M, Schonfeldt-Lecuona C (2001) Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry 50:58-61
20. Hurley S (2002) Lamotrigine update and its use in mood disorders. Ann Pharmacother 36:860-873
21. Ketter TA, Calabrese JR (2002) Stabilization of mood, from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 63:146-151
22. Ketter TA, Manji HK, Post RM (2003) Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 23:484-495
23. Koski L, Paus T (2000) Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brain-mapping meta-analysis. Exp Brain Res 133:55-65
24. Large CH, Daniel ED, Li X, George MS (2009) Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine. Biochem Soc Trans 37:1080-1084
25. Li X, Nahas Z, Kozel FA, Anderson B, Bohning DE, George MS (2004a) Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical, as well as subcortical regions. Biol Psychiatiy 55:882-890
26. Li X, Teneback CC, Nahas Z, Kozel FA, Large C, Cohn J, Bohning DE, George MS (2004b) Interleaved, transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 29:1395-1407 (Pubitemid 38780663)
27. Li X, Ricci R, Large CH, Anderson B, Nahas Z, George MS (2009) Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm 116:423-429
28. Loscher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342:1-13
29. Loscher WN, Nordlund MM (2002) Central fatigue and motor cortical excitability during repeated shortening and lengthening actions. Muscle Nerve 25:864-872
30. Manganotti P, Bongiovanni LG, Zanette G, Turazzini M, Fiaschi A (1999) Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40:316-321
31. Margulies DS, Kelly AM, Uddin LQ, Biswal BB, Castellanos FX, Milham MP (2007) Mapping the functional connectivity of anterior cingulate cortex. Neuroimage 37:579-588
32. Messenheimer JA (1995) Lamotrigine. Epilepsia 36(Suppl 2):S87-S94
33. Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C, McConnell K, Vincent DJ, Li X, George MS, Bohning DE (2001) Unilateral left prefrontal transcranial magnetic stimulation (IMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry JID0213264 50:712-720
34. Paulus W, Classen J, Cohen LG, Large CH, Di Lazzaro V, Nitsche M, Pascual-Leone A, Rothwell JC, Ziemann U (2008) State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimulation 2:151163
35. Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553-564
36. Shastri A, George MS, Bohning DE (1999) Performance of a system for interleaving transcranial magnetic stimulation with steadystate magnetic resonance imaging. Electroencephalogr Clin Neurophysiol Suppl 51:55-64
37. Tracey I (2001) Prospects for human pharmacological functional magnetic resonance imaging (phMRI). J Clin Pharmacol Suppl:21S-28S
38. Wise RG, Tracey I (2006) The role of fMRI in drug discovery. J Magn Reson Imaging 23:862-876
39. Xie X, Hagan RM (1998) Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38:119-130
40. Xie X, Lancaster B, Peakman T, Garthwaite J (1995) Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+channels and with, native Na+channels in rat hippocampal neurones. Pflugers Arch. 430:437-446
41. Zaceara G, Messori A, Moroni F (1988) Clinical pharmacokinetics of valproic acid-1988. Clin Pharmacokinet 15:367-389
42. Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115:17171729
43. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996) Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40:367-378 (Pubitemid 26304794)
44. Ziemann U, Steinhoff BJ, Tergau F, Paulus W (1998) Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 30:11-30
45. Ziemann U, Tam. A, Butefisch C, Cohen LG (2002) Dual modulating effects of amphetamine on neuronal excitability and stimulationinduced plasticity in human motor cortex. Clin Neurophysiol 113:1308-1315